-
PU Prime Deepens Argentina Presence Through FX Expo Buenos Aires 2026
-
PU Prime Strengthens UAE Momentum with Strong Showing at Forex Expo Dubai 2026
-
Nothing to seal here: NZ police help stranded pup home
-
Eight dead in Thailand floods since mid-September
-
White House releases list of products US, China could tax less
-
Oil prices spike after Trump rejects Iran truce offer
-
'Pseudo-journalism': Partisan 'news' sites target US midterms
-
Taylor Swift sets new record at MTV VMAs
-
'Currently impossible': North Korea defections in freefall
-
Seoul seeks apology after Ukraine reveals transfer of North Korean POWs
-
Erasmus sizes up 'improved' Wallabies ahead of 2027 World Cup
-
Messi on target again but Miami downed by Columbus
-
Scandal-weary Brazilians to vote as Lula faces Bolsonaro son
-
In Washington's political cauldron, a fight over foie gras
-
SpaceX aims to put Starship in orbit for the first time
-
Flavio Bolsonaro: political heir in his father's shadow
-
Pope to speak on united Europe from French border town
-
Ravens grab last-second win in Rio as Commanders stop Seahawks
-
Scheffler makes sportsmanship stand over tee screamer
-
USA rallies to capture 11th consecutive Presidents Cup
-
Anthropic CEO Amodei to dine with Trump at White House
-
Phillies clinch, Astros wrap up division on final day of MLB season
-
Dupont scores twice to send Toulouse to Top 14 summit
-
Commanders hand champion Seahawks their first loss
-
Greece stun Klopp's Germany as Ireland show sorrow for Gaza
-
Dupont scores twice to send Toulouse top of Top 14
-
Ramos fires holders Portugal to Nations League win in Norway
-
Ireland beat Israel but no handshakes due to war in Gaza
-
Greece hand Klopp first defeat as Germany manager
-
Tense standoff over flashpoint N.Ireland parade lasts into night
-
Pope promises French sex abuse victims to prevent further harm
-
Stunned McNulty wins 'miracle' road race world title
-
UK village on edge over threats to air base in terror alert
-
Re-released 'Avengers: Endgame' snaps-up N. America box office lead
-
Two giant pandas, emblems of China soft diplomacy, arrive in US
-
American McNulty wins shock road race world title
-
Aleksandar Vucic: from Milosevic minister to long-serving Serbian statesman
-
Serbia's President Aleksandar Vucic announces resignation
-
Trump expects new Iran talks despite rejecting deal offer
-
Tuchel urges Bellingham to play with 'rage'
-
Xavi gets first win as Netherlands boss, Denmark beat Wales
-
Russian strikes on Ukraine kill 8
-
Madrid housing protest camp enters second night as PM vows action
-
Bavuma, Miller hit centuries as South Africa clinch series
-
Tigray TV station hit by drone, rebels advance in north Ethiopia
-
Spain bring in Le Normand for injured Garcia
-
Banton hundred paves way for England ODI series win over Sri Lanka
-
UK Labour party meets buoyed by Burnham but seeking concrete plans
-
Milestone man Kohli powers India to big ODI win over West Indies
-
Nor'easter lashes US east with punishing rain and wind
Ghostwriters, polo shirts, and the fall of a landmark pesticide study
A flagship study that declared the weedkiller Roundup posed no serious health risks has been retracted with little fanfare, ending a 25-year saga that exposed how corporate interests can distort scientific research and influence government decision-making.
Published in Regulatory Toxicology and Pharmacology in 2000, the paper ranks in the top 0.1 percent of citations among studies on glyphosate -- the key ingredient in Roundup, owned by agri-giant Monsanto and at the center of cancer lawsuits worth billions of dollars.
In his retraction note last week, the journal's editor-in-chief, Martin van den Berg, cited a litany of serious flaws from failing to include carcinogenicity studies available at the time to undisclosed contributions by Monsanto employees and even questions around financial compensation.
Elsevier, the journal's Dutch publisher, told AFP in a statement that it upholds the "highest standards of rigor and ethics" and that "as soon as the current editor became aware of concerns regarding this paper a matter of months ago, due process began."
But it did not address the fact that concerns date back to 2002, when critics wrote to Elsevier about "conflicts of interest, lack of transparency, and the absence of editorial independence" at the journal, including specific worries about Monsanto.
The matter exploded into public view in 2017, when internal corporate documents released during litigation showed one of Monsanto's own scientists admitting to "ghostwriting."
Harvard University science historian Naomi Oreskes, who co-authored a paper this September detailing the extent of the "fraud" in the 2000 study, told AFP that while she was "very gratified" at the "long overdue" action, but warned that "the scientific community needs better mechanisms to identify and retract fraudulent papers."
"This is completely in alignment with what we were calling them out for at the time," Lynn Goldman, a pediatrician and epidemiologist at GWU who co-signed the 2002 letter, added to AFP.
- Polo shirts -
Two of the paper's three original authors have since died, while first author Gary Williams, a professor at New York Medical College, did not respond to AFP's request for comment.
Monsanto maintains it acted appropriately, and that its product is safe. "Monsanto's involvement with the Williams et al paper did not rise to the level of authorship and was appropriately disclosed in the acknowledgments."
The company declined to comment on internal emails that suggested otherwise, including one in which a Monsanto scientist asked a colleague whether "the team of people" who worked on the Williams paper and another study "could receive Roundup polo shorts as a token of appreciation for a job well done."
Glyphosate was brought to market as a herbicide in the 1970s and initially welcomed as less toxic than DDT.
But its soaring use -- especially after Monsanto introduced glyphosate-tolerant seeds that allowed it to be sprayed widely over crops -- drew increasing scrutiny in the 1990s, making the 2000 paper hugely influential.
According to Oreskes's research, it was cited as supporting evidence for glyphosate's safety by groups ranging from the Canadian Forest Service to the International Court of Justice, the US Congress and the European Parliamentary Research Service.
- Legal interest -
In 2015, the World Health Organization's International Agency for Research on Cancer classified glyphosate as "probably carcinogenic to humans."
Several countries have since moved to restrict or ban its use, including France, which has prohibited household applications. Bayer, which acquired Monsanto, said it would phase out Roundup for US residential use in 2023 in response to growing lawsuits.
Nathan Donley, a scientist with the Center for Biological Diversity, told AFP he does not expect the retraction to sway the US Environmental Protection Agency, now under the pro-agricultural-industry Donald Trump administration, which has thrown its weight behind Bayer in an ongoing Supreme Court case.
But "it could play a role in litigation that is moving forward in the US against the EPA's proposed decision to renew glyphosate," Donley told AFP, adding that European regulators might also take note.
For Donley and others, the deeper concern is that the case may be far from unique.
"I am sure there (are a) lot (of) such ghost-written and undeclared conflict papers in the literature, but they are very difficult to unearth unless one goes really deep in litigation cases," John Ioannidis, a Stanford University professor who founded the field of meta-research told AFP.
L.AbuTayeh--SF-PST